SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,570 | -57.4% | 10,954 | -7.7% | 0.00% | – |
| Q2 2023 | $15,432 | -72.3% | 11,871 | -62.5% | 0.00% | – |
| Q1 2023 | $55,739 | -43.9% | 31,670 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $99,444 | -21.1% | 31,670 | +23.5% | 0.00% | 0.0% |
| Q3 2022 | $126,000 | +17.8% | 25,641 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $107,000 | -32.3% | 25,874 | -5.0% | 0.00% | 0.0% |
| Q1 2022 | $158,000 | -31.6% | 27,241 | -11.6% | 0.00% | 0.0% |
| Q4 2021 | $231,000 | -18.4% | 30,809 | -1.9% | 0.00% | -50.0% |
| Q3 2021 | $283,000 | -24.7% | 31,405 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $376,000 | -1.6% | 31,385 | +2.9% | 0.00% | 0.0% |
| Q1 2021 | $382,000 | +49.2% | 30,486 | +85.8% | 0.00% | 0.0% |
| Q4 2020 | $256,000 | +65.2% | 16,411 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $155,000 | +5.4% | 16,411 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $147,000 | +70.9% | 16,411 | +21.8% | 0.00% | 0.0% |
| Q1 2020 | $86,000 | +48.3% | 13,477 | +95.7% | 0.00% | – |
| Q4 2019 | $58,000 | -6.5% | 6,887 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $62,000 | -16.2% | 6,887 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $74,000 | +17.5% | 6,887 | +4.1% | 0.00% | 0.0% |
| Q1 2019 | $63,000 | -19.2% | 6,618 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $78,000 | -12.4% | 6,787 | +29.6% | 0.00% | 0.0% |
| Q3 2018 | $89,000 | +32.8% | 5,235 | +11.1% | 0.00% | 0.0% |
| Q2 2018 | $67,000 | -25.6% | 4,711 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $90,000 | +16.9% | 4,711 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $77,000 | +120.0% | 4,711 | +100.7% | 0.00% | – |
| Q3 2017 | $35,000 | +66.7% | 2,347 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | +75.0% | 2,347 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | +71.4% | 2,347 | 0.0% | 0.00% | – |
| Q4 2016 | $7,000 | -36.4% | 2,347 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -21.4% | 2,347 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | 0.0% | 2,347 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | -33.3% | 2,347 | 0.0% | 0.00% | – |
| Q4 2015 | $21,000 | +320.0% | 2,347 | +164.3% | 0.00% | – |
| Q3 2015 | $5,000 | +25.0% | 888 | +176.6% | 0.00% | – |
| Q2 2015 | $4,000 | -20.0% | 321 | 0.0% | 0.00% | – |
| Q1 2015 | $5,000 | – | 321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |